warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
Forum EVP-6124-025
Brief Description  
This study is to evaluate the safety and efficacy of EVP-6124 (2 or 3 mg daily) compared with placebo for 26 weeks in subjects with mild to moderate dementia due to Alzheimer's Disease currently or previously treated with an AChE1 medication
Who may be Eligible  
Male or female ages 55-85
Speciality/Disorder  
Alzheimer´s Disease
Start Date  
10/01/2014
IRB Number  
C-191
Principal Investigator  
Tcheremissine, Oleg
Contact Name  
Dineen

For More Information, Contact  Dineen  , Gardner
Phone:  (704) 446-7511  Fax:  (704) 446-7505  
Email:  dgardner@carolinas.org
Address:465 N. Wendover Road Charlotte, NC 28211
Close